RESUMEN
(1) Background: Riparin-A presents several pharmacological activities already elucidated, such as antimicrobial modulator, antileishmania, anxiolytic, anti-inflammatory, antinociceptive, and antioxidant. Even with important bioactive effects, the applicability of Riparin-A is limited due to its low solubility in water, impairing its dissolution in biological fluids. Thus, the objective of this study was to develop a nanohybrid based on Riparin-A and Laponite to obtain a better dissolution profile and evaluate its cytotoxic potential. (2) Methods: The formation of a hybrid system was highlighted by X-ray powder diffraction, infrared spectroscopy, and thermal analysis. Solubility, dissolution, and cytotoxicity studies were performed; (3) Results: An increase in the solubility and aqueous dissolution rate of Riparin-A was observed in the presence of clay. Diffractometric analysis of the hybrid system suggests the amorphization of Riparin-A, and thermal analyses indicated attenuation of decomposition and melting of the Riparin-A after interaction with clay. Furthermore, the nanosystem did not exhibit cytotoxic activity on normal and tumorigenic lines. (4) Conclusions: These results are promising for the development of the Riparin-A/Laponite nanosystem for therapeutic purposes, suggesting an increase in the range of possible routes of administration and bioavailability of this bioactive compound.
RESUMEN
Acinetobacter baumannii is an important opportunistic pathogen that causes serious health-related infections, especially in intensive care units. The present study aimed to investigate the antimicrobial activity of Riparin-B (Rip-B) alone and in association with norfloxacin against multidrug-resistant clinical isolates of A. baumannii. For this, the minimum inhibitory concentrations were determined by the microdilution method. For the evaluation of resistance-modulating activity, MIC values for antibiotics were determined in the presence or absence of subinhibitory concentrations of Rip-B or chlorpromazine (CPZ). The AdeABC-AdeRS efflux system genes from these isolates were detected by PCR. Docking studies were also carried out to evaluate the interaction of Riparin-B and the AdeABC-AdeRS efflux system. The study was conducted from 2017 to 2019. The results showed that Rip-B showed weak intrinsic activity against the strains tested. On the other hand, Rip-B was able to modulate norfloxacin's response against A. baumannii strains that express efflux pump-mediated resistance. Docking studies provided projections of the interaction between Rip-B and EtBr with the AdeB protein, suggesting that Rip-B acts by competitive inhibition with the drug. Results found by in vitro and in silico assays suggest that Rip-B, in combination with norfloxacin, has the potential to treat infections caused by multidrug-resistant A. baumanni with efflux pump resistance.
RESUMEN
Stress is crucially related to the pathophysiology of mood disorders, including depression. Since the effectiveness and number of the current pharmacological options still presents significant limitations, research on new substances is paramount. In rodents, several findings have indicated that corticosterone administration induces the manifestation of behavioral and neurochemical aspects of depression. Recently, riparin III has shown antidepressant-like properties in trials performed on animal models. Thus, our goal was to investigate the effects of riparin III on behavioral tests, monoamines levels, oxidative stress and cytokines levels in chronic corticosterone-induced model of depression. To do this, female swiss mice were treated with subcutaneous administration of corticosterone for 22 days. In addition, for the last 10 days, riparin III or fluvoxamine were also administered per os in specific test groups. Control groups received subcutaneous saline injections or distilled water per os. At the end of the timeline, the animals were killed and their hippocampi, prefrontal cortex, and striatum dissected for neurochemical analysis. Brain changes following corticosterone administration were confirmed, and riparin III could reversed the most abnormal behavioral and neurochemical corticosterone-induced alterations. These results suggest the potential antioxidant, anti-inflammatory and antidepressant effects of riparin III after a chronic stress exposure.
Asunto(s)
Depresión , Preparaciones Farmacéuticas , Animales , Conducta Animal , Benzamidas , Corticosterona , Depresión/tratamiento farmacológico , Modelos Animales de Enfermedad , Femenino , Ratones , Tiramina/análogos & derivadosRESUMEN
Natural products have been used to treat various infections; however, the development of antimicrobials has made natural products in disuse. Riparin I, II and III are natural alkamide isolated from Aniba riparia (Ness) Mez (Lauraceae), that exhibit economic importance and it is used in traditional medicine, and popularly known as "louro". This study investigated the cytotoxicity, antimicrobial and antibiofilm activity, and ultrastructural changes in vitro by riparins I, II and III in Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa. We analyzed the cytotoxicity by MTT assay in Vero cells and hemolytic action verified in human erythrocytes. The antimicrobial activity was determined by microdilution in broth against ATCC strains, identifying the susceptible species. Subsequently, only the MDR isolates of sensitive bacterial species were evaluated regarding its biofilm formation and ultrastructural changes. Riparin I presented low cytotoxicity and hemolytic percentage ranging from of 9.01%-12.97%. Only the riparin III that showed antimicrobial activity against MDR clinical isolates, and significant reduction in biofilm formation in S. aureus. Moreover, the riparin III promoted ultrastructural changes in bacterial cells, such as elongated cellular without bacterial septum, cells with a rugged appearance on the cell surface and cytoplasmic material extravasation. As has been noted riparin III has an inhibitory potential against biofilm formation in S. aureus, besides having antimicrobial activity and promoting ultrastructural changes in MDR clinical isolates. Thus, riparin III is an interesting alternative for further studies aiming to develop new therapeutic options.
Asunto(s)
Farmacorresistencia Bacteriana Múltiple , Staphylococcus aureus , Animales , Antibacterianos/farmacología , Biopelículas , Chlorocebus aethiops , Humanos , Pruebas de Sensibilidad Microbiana , Células VeroRESUMEN
BACKGROUND: Cognitive impairment is identified as one of the diagnostic criteria for major depressive disorder and can extensively affect the quality of life of patients. Based on these findings, this study aimed to investigate the possible effects of Riparin IV (Rip IV) on cognitive impairment induced by chronic administration of corticosterone in mice. METHODS: Female Swiss mice were divided into four groups: control (Control), corticosterone (Cort), Riparin IV (Cort + Rip IV), and Fluvoxamine (Cort + Flu). Three groups were administered corticosterone (20 mg/kg) subcutaneously during the 22-day study, while the control group received only vehicle. After the 14th day, the groups were administered medications: Riparin IV (Rip IV), fluvoxamine (Flu), or distilled water, by gavage, 1 h after the subcutaneous injections. After treatment, mice underwent behavioral testing, and brain areas were removed for oxidative stress and cytokine content assays. RESULTS: The results revealed that Cort-treated mice developed a cognitive impairment and exhibited a neuroinflammatory profile with an oxidative load and Th1/Th2 cytokine imbalance. Rip IV treatment significantly ameliorated the cognitive deficit induced by Cort and displayed a neuroprotective effect. CONCLUSION: The antidepressant-like ability of Rip IV treatment against chronic Cort-induced stress may be due to its potential to mitigate inflammatory damage and oxidative stress. The antioxidant and anti-inflammatory effect observed indicates Rip IV as a possible drug for antidepressant treatment of non-responsive patients with severe and cognitive symptoms.
Asunto(s)
Disfunción Cognitiva/prevención & control , Encefalitis/tratamiento farmacológico , Fármacos Neuroprotectores/farmacología , Estrés Oxidativo/efectos de los fármacos , Estrés Psicológico/tratamiento farmacológico , Tiramina/análogos & derivados , Animales , Antioxidantes/farmacología , Conducta Animal/efectos de los fármacos , Encéfalo/efectos de los fármacos , Encéfalo/metabolismo , Encéfalo/patología , Enfermedad Crónica , Disfunción Cognitiva/etiología , Disfunción Cognitiva/metabolismo , Corticosterona/metabolismo , Depresión/tratamiento farmacológico , Depresión/etiología , Depresión/metabolismo , Encefalitis/complicaciones , Encefalitis/metabolismo , Femenino , Masculino , Ratones , Estrés Psicológico/complicaciones , Estrés Psicológico/metabolismo , Estrés Psicológico/psicología , Tiramina/farmacologíaRESUMEN
We have reported Riparin A as a promising antiparasitic molecule ââagainst Leishmania amazonensis promastigotes. This work evaluated the acute oral toxicity of Riparin A and its anxiolytic effects using in vivo models and computational tools. Mice were submitted to acute oral toxicity tests (Guideline OECD 423). Later, anxiety assays with Riparin A (50, 100 and 200â¯mg/kg: elevated plus maze, light/dark box and marble burying) were performed. Theoretical calculations analyzed interaction of Riparin A with gamma-amino butyric acid (GABA) receptors. Only Riparin A at 2000â¯mg/kg alter body weight, food and water consumption and urine production after 7 and/or 14 days treatment and increased serum triglycerides. There was increase in the time spent in the open arms (TSOA) and number of transitions between compartments (NTC) and decrease in number of hidden balls (NHB) in Riparin A-treated animals at 200â¯mg/kg (Pâ¯<â¯0.05), whose approximate ED50 was 283.1 (156.5-397.1) mg/kg. The functional amide of Riparin A interacted with the GABAA receptor mainly at subunits α2 and ß1 and presented strong interaction with the Asp68 residue, which is part of the pharmacophore group. Riparin A was toxically safe and pharmacologically active for anxiolytic purposes, revealed NOAEL of 200â¯mg/kg and probably interacts with Asp68 residues of benzodiazepine receptors by hydrogen bonds.
Asunto(s)
Ansiolíticos/farmacología , Ansiolíticos/toxicidad , Conducta Animal/efectos de los fármacos , Benzamidas/farmacología , Benzamidas/toxicidad , Fenetilaminas/farmacología , Fenetilaminas/toxicidad , Receptores de GABA-A/metabolismo , Animales , Femenino , Hipocampo/efectos de los fármacos , Hipocampo/patología , Aprendizaje por Laberinto/efectos de los fármacos , Ratones , Actividad Motora/efectos de los fármacos , Nivel sin Efectos Adversos Observados , Bazo/efectos de los fármacos , Bazo/patología , Pruebas de Toxicidad AgudaRESUMEN
Benzoyltryptamine analogues act as neuroprotective and spasmolytic agents on smooth muscles. In this study, we investigated the ability of N-salicyloyltryptamine (STP) to produce vasorelaxation and determined its underlying mechanisms of action. Isolated rat mesenteric arteries with and without functional endothelium were studied in an isometric contraction system in the presence or absence of pharmacological inhibitors. Amperometric experiments were used to measure the nitric oxide (NO) levels in CD31+ cells using flow cytometry. GH3 cells were used to measure Ca2+ currents using the whole cell patch clamp technique. STP caused endothelium-dependent and -independent relaxation in mesenteric rings. The endothelial-dependent relaxations in response to STP were markedly reduced by L-NAME (endothelial NO synthase-eNOS-inhibitor), jHydroxocobalamin (NO scavenger, 30 µM) and ODQ (soluble Guanylyl Cyclase-sGC-inhibitor, 10 µM), but were not affected by the inhibition of the formation of vasoactive prostanoids. These results were reinforced by the increased NO levels observed in the amperometric experiments with freshly dispersed CD31+ cells. The endothelium-independent effect appeared to involve the inhibition of voltage-gated Ca2+ channels, due to the inhibition of the concentration-response Ca2+ curves in depolarizing solution, the increased relaxation in rings that were pre-incubated with high extracellular KCl (80 mM), and the inhibition of macroscopic Ca2+ currents. The present findings show that the activation of the NO/sGC/cGMP pathway and the inhibition of gated-voltage Ca2+ channels are the mechanisms underlying the effect of STP on mesenteric arteries.
Asunto(s)
Señalización del Calcio/efectos de los fármacos , Endotelio Vascular/metabolismo , Arterias Mesentéricas/metabolismo , Óxido Nítrico/metabolismo , Salicilatos/farmacología , Guanilil Ciclasa Soluble/metabolismo , Triptaminas/farmacología , Vasodilatación/efectos de los fármacos , Animales , Masculino , Ratas , Ratas Wistar , Salicilatos/química , Triptaminas/químicaRESUMEN
The green Brazilian bay leaf, a spice much prized in local cuisine (Aniba riparia, Lauraceae), contains chemical compounds presenting benzoyl-derivatives named riparins, which have anti-inflammatory, antimicrobial and anxiolytic properties. However, it is unclear what kind of interaction riparins perform with any molecular target. As a profitable target, human serum albumin (HSA) is one of the principal extracellular proteins, with an exceptional capacity to interact with several molecules, and it also plays a crucial role in the transport, distribution, and metabolism of a wide variety of endogenous and exogenous ligands. To outline the HSA-riparin interaction mechanism, spectroscopy and computational methods were synergistically applied. An evaluation through fluorescence spectroscopy showed that the emission, attributed to Trp 214, at 346 nm decreased with titrations of riparins. A static quenching mechanism was observed in the binding of riparins to HSA. Fluorescence experiments performed at 298, 308 and 318 K made it possible to conduct thermodynamic analysis indicating a spontaneous reaction in the complex formation (ΔG<0). The enthalpy-entropy balance experiment with a molecular modeling calculation revealed that hydrophobic, hydrogen bond and non-specific interactions are present for riparin I-III with HSA. The set of results from fractional fluorescence changes obtained through Schatchard was inconclusive in establishing what kind of cooperativity is present in the interaction. To shed light upon the HSA-riparins complex, Hill's approach was utilized to distinguish the index of affinity and the binding constant. A correspondence between the molecular structures of riparins, due to the presence of the hydroxyl group in the B-ring, with thermodynamic parameters and index of affinity were observed. Riparin III performs an intramolecular hydrogen bond, which affects the Hill coefficient and the binding constant. Therefore, the presence of hydroxyl groups is capable of modulating the interaction between riparins and HSA. Site marker competitive experiments indicated Site I as being the most suitable, and the molecular modeling tools reinforced the experimental results detailing the participation of residues.
Asunto(s)
Benzamidas/metabolismo , Albúmina Sérica Humana/metabolismo , Benzamidas/química , Humanos , Cinética , Ligandos , Modelos Moleculares , Unión Proteica , Albúmina Sérica Humana/química , Espectrometría de Fluorescencia , TermodinámicaRESUMEN
Riparins, natural alkaloids of the alkamide group, can be synthesized by simple methods, enhancing their potential application in pharmaceutical development. Here, the pharmacological properties of riparins were investigated in in vitro and in vivo assays of pain and inflammation in Swiss mice. Inflammatory mediators were measured by radioimmunoassay and Real-Time PCR. Riparins I, II, III and IV (1.56-100 mg/kg; ip) produced dose-related antinociceptive effects in the formalin test, exhibiting ED50 values of 22.93, 114.2, 31.05 and 6.63 mg/kg, respectively. Taking the greater potency as steering parameter, riparin IV was further investigated. Riparin IV did not produce antinociceptive effect on the tail flick, suggesting that its antinociception is not a centrally-mediated action. In fact, riparin IV (1.56-25 mg/kg) produced dose-related antinociceptive and antiedematogenic effects on the complete Freund's adjuvant (CFA)-induced paw inflammation in mice. During CFA-induced inflammation, riparin IV did not modulate either the production of cytokines, TNF-α and IL-10, or COX-2 mRNA expression. On the other hand, riparin IV decreased the PGE2 levels in the inflamed paw. In in vitro assays, riparin IV did not exhibit suppressive activities in activated macrophages. These results indicate, for the first time, that riparin IV induces antinociceptive and anti-inflammatory effects, possibly through the inhibition of prostanoid production.
Asunto(s)
Alcaloides/farmacología , Analgésicos/farmacología , Antiinflamatorios/farmacología , Benzamidas/farmacología , Edema/tratamiento farmacológico , Dolor/tratamiento farmacológico , Animales , Ciclooxigenasa 2/genética , Ciclooxigenasa 2/inmunología , Dinoprostona/antagonistas & inhibidores , Dinoprostona/biosíntesis , Dinoprostona/inmunología , Edema/inducido químicamente , Edema/inmunología , Edema/patología , Adyuvante de Freund/efectos adversos , Expresión Génica , Inflamación , Interleucina-10/genética , Interleucina-10/inmunología , Masculino , Ratones , Dolor/inducido químicamente , Dolor/inmunología , Dolor/patología , Manejo del Dolor , Dimensión del Dolor , Percepción del Dolor/efectos de los fármacos , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/inmunologíaRESUMEN
Aniba riparia (Lauraceae) is an important medicinal plant found in the Amazon region and presents alkaloids of the type alkamide known as riparins. Riparin A is structurally represented as the fundamental core of all Amazon riparins. This work aimed to assess the in vitro antioxidant, antitumor and antileishmanial effects of riparin A. Riparin A presented weak antioxidant capacity by tecniques of DPPH (EC50 of 296.2 μg mL-1) and ABTS+ (EC50 of 450.1 μg mL-1), showed moderate activity against colon carcinoma (HCT-116: IC50 of 21.7 μg mL-1) and leishmanicidal activity on promastigotes of L. amazonensis (IC50 of 307.0 ± 79.6, 193.7 ± 44.3 and 81.8 ± 11.2 μg mL-1, respectively, after 24, 48 and 72 h of incubation). Then, in addition to its structural simplicity, riparin A revealed promising biological activities and remarkable in vitro leishmanicidal action, an important result in epidemiological point of view to control leishmaniasis in Brazil, including in the Amazon region.
Aniba riparia (Lauraceae) é uma importante planta medicinal encontrada na região amazônica que apresenta alcaloides do tipo alcamida e conhecidos como riparinas. Este trabalho teve como objetivo avaliar os efeitos antioxidantes, antitumorais e leishmanicidas in vitro da riparina A. Riparina A apresentou fraca capacidade antioxidante pelas técnicas do DPPH (CE50 de 296,2 μg mL-1) e ABTS+ (CE50 de 450,1 μg mL-1), mostrou moderada atividade contra carcinoma de cólon (HCT-116: CI50 de 21,7 μg mL-1) e atividade leishmanicida sobre formas promastigotas de Leishmania amazonensis (CI50 de 307,0 ± 79,6; 193,7 ± 44,3 e 81,8 ± 11,2 μg mL-1, respectivamente, após 24, 48 e 72 h de incubação). Assim, além de sua simplicidade estrutural, a riparina A revelou atividades biológicas promissoras e significativa ação leishmanicida in vitro, resultado importante diante da relevância epidemiológica para controle da leishmaniose no Brasil, inclusive na região amazônica.
Asunto(s)
Antiparasitarios , Bioprospección , Citotoxinas/análisis , Lauraceae/química , Antioxidantes , Ensayos de Selección de Medicamentos Antitumorales , LeishmaniaRESUMEN
The aim of our study was to evaluate the anti-inflammatory, anti-nociceptive, and anti-oxidant action of Riparin B in vivo. We performed experiments in which we induced paw edema by carrageenan and other mediators, carrageenan-induced peritonitis and the level of myeloperoxidase (MPO) activity, pro-inflammatory cytokines (TNF-α and IL-1ß), malondialdehyde (MDA) acid, and glutathione (GSH) from the peritoneal fluid. We also performed behavior tests such as acetic acid-induced writhing, formalin-induced linking, and the hot plate test. Among the doses tested of the Riparin B (1, 3, and 10 mg/kg), the dose of 10 mg/kg showed the strongest effect, and this dose was able to reduce the paw edema induced by carrageenan, dextran, histamine serotonin, bradykinin, 48/80, and PGE2. Similarly, the Riparin B in the same dose reduced cell migration and significantly decreased the nociception induced by formalin and acetic acid and reversed the parameters of the oxidative stress. Thus, we can infer that Riparin B exhibits anti-inflammatory, anti-nociceptive, and anti-oxidant actions in vivo.
Asunto(s)
Antiinflamatorios/farmacología , Antioxidantes/farmacología , Benzamidas/farmacología , Citocinas/metabolismo , Edema/prevención & control , Mediadores de Inflamación/metabolismo , Estrés Oxidativo/efectos de los fármacos , Peritonitis/prevención & control , Fenetilaminas/farmacología , Analgésicos/farmacología , Animales , Carragenina , Citocinas/inmunología , Modelos Animales de Enfermedad , Edema/inducido químicamente , Edema/inmunología , Edema/metabolismo , Glutatión/metabolismo , Mediadores de Inflamación/inmunología , Masculino , Malondialdehído/metabolismo , Ratones , Infiltración Neutrófila/efectos de los fármacos , Dolor Nociceptivo/inducido químicamente , Dolor Nociceptivo/metabolismo , Dolor Nociceptivo/prevención & control , Peritonitis/inducido químicamente , Peritonitis/inmunología , Peritonitis/metabolismo , Peroxidasa/metabolismo , Factores de TiempoRESUMEN
AIMS: This study aimed at evaluating the oxidative stress in mitochondria isolated from the brain and liver of mice treated with riparin A, as well as the locomotor activity and myorelaxant effect of this compound. Behavioral models of rota rod and open field tests were used for locomotor activity and myorelaxant effect evaluation. MAIN METHODS: The animals were divided into five groups (n=8), which were treated with: diazepam (1mg/kg, i.p), riparin A (5, 10, and 20mg/kg, o.r.) or vehicle (0.9% saline, o.r.). The oxidative stress evaluation was carried out in mitochondria isolated from the brain and liver of mice from five experimental groups (n=8), which were treated with: ascorbic acid (250 mg/kg; positive control), vehicle (0.9% saline; negative control) and riparin A (5, 10 and 20mg/kg). KEY FINDINGS: In an open field and rota rod test a significant difference in the number of crossings, in time of permanence on the swivel bar and in the number of falls in riparin A treated animals (5, 10 and 20mg/kg) was not observed, when compared with negative control (vehicle) (p>0.05). In comparison to the negative control, there was a reduction of lipid peroxidation levels and nitrite content in mice treated with riparin A (p<0.05). Reduced glutathione (GSH) levels (p<0.05), superoxide dismutase (SOD) and catalase activities increased in the brain (rip A 5mg/kg; p<0.05), while in the liver SOD remained unchanged (p>0.05) and catalase activity (p<0.05) was reduced. SIGNIFICANCE: Riparin A was presented as a bioactive molecule devoid of adverse effects of alteration of motor activity.
Asunto(s)
Antioxidantes/farmacología , Conducta Animal/efectos de los fármacos , Benzamidas/farmacología , Química Encefálica/efectos de los fármacos , Mitocondrias Hepáticas/metabolismo , Mitocondrias/metabolismo , Estrés Oxidativo/efectos de los fármacos , Fenetilaminas/farmacología , Animales , Peroxidación de Lípido/efectos de los fármacos , Masculino , Ratones , Mitocondrias/efectos de los fármacos , Mitocondrias Hepáticas/efectos de los fármacos , Actividad Motora/efectos de los fármacos , Relajantes Musculares Centrales/farmacología , Nitritos/metabolismo , Equilibrio Postural/efectos de los fármacosRESUMEN
Riparin II (RipII), an alkamide isolated from the green fruit of Aniba riparia, was tested in the various animal models of inflammation to investigate its anti-inflammatory activity. Male Wistar rats (180-240g) were treated with RipII by gavage at doses 25 or 50mg/kg, before initiating the inflammatory responses. The tests used were paw edema induced by carrageenan, dextran, histamine or serotonin; peritonitis induced by carrageenan and fMLP, as well as the measurement of MPO activity, TNF-α and Il-1ß amount in the peritoneal fluid. In the animal models of carrageenan and dextran-induced paw edema, the animals treated with RipII showed lower edema than those of the control group. Treatment with RipII also reduced the paw edema induced by histamine but not serotonin. In the carrageenan-induced peritonitis model, treatment with RipII reduced leukocyte migration, the MPO activity and the amount of TNF-α and IL-1ß in the peritoneal fluid. In summary, these results indicate that RipII has an anti-inflammatory activity in chemical models of acute inflammation. RipII might be directly or indirectly inhibiting the activity, production or release of pro-inflammatory mediators involved in the generation of the pain associated with inflammation.
Asunto(s)
Antiinflamatorios/farmacología , Benzamidas/farmacología , Inflamación/tratamiento farmacológico , Tiramina/análogos & derivados , Animales , Modelos Animales de Enfermedad , Edema/inducido químicamente , Edema/tratamiento farmacológico , Inflamación/inducido químicamente , Masculino , Malondialdehído/metabolismo , Ratones , Peritonitis/inducido químicamente , Peritonitis/tratamiento farmacológico , Ratas , Ratas Wistar , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Tiramina/farmacologíaRESUMEN
Immunomodulatory actions exerted by some classes of tryptamines, such as benzoyltryptamine analogues, suggest these molecules as promising candidates to develop new therapies to treat conditions associated to acute and chronic pain and inflammation. N-salicyloyltryptamine (STP) was observed to act as an anticonvulsive agent and exert antinociceptive effects in mouse. In the present work, we performed a screening of cytotoxic, cytoprotective, immunomodulatory, and redox properties of STP in RAW 264.7 macrophages challenged with hydrogen peroxide and LPS. Our results show that STP presents no cytotoxicity in the range of 0.001 to 1 µg/mL, but doses of 50 and 100 µg/mL caused loss of cell viability (IC(50) = 22.75 µg/mL). Similarly, STP at 0.001 to 1 µg/mL did not cause oxidative stress to RAW 264.7 cells, although it did not prevent cell death induced by H(2)O(2) 0.5 mM. At 1 µg/mL, STP reversed some redox and inflammatory parameters induced by LPS. These include thiol (sulfhydryl) oxidation, superoxide dismutase activation, and morphological changes associated to macrophage activation. Besides, STP significantly inhibited LPS-induced TNF-α and IL-1ß release, as well as CD40 and TNF-α protein upregulation. Signaling events induced by LPS, such as phosphorylation of ERK 1/2 and IκBα and p65 nuclear translocation (NF-kB activation) were also inhibited by STP. These data indicate that STP is able to modulate inflammatory parameters at doses that do not interfere in cell viability.
Asunto(s)
Inmunomodulación , Activación de Macrófagos/efectos de los fármacos , Macrófagos/efectos de los fármacos , Salicilatos/farmacología , Triptaminas/farmacología , Animales , Línea Celular , Supervivencia Celular/efectos de los fármacos , Regulación de la Expresión Génica , Peróxido de Hidrógeno/farmacología , Proteínas I-kappa B/genética , Proteínas I-kappa B/inmunología , Concentración 50 Inhibidora , Interleucina-1beta/antagonistas & inhibidores , Interleucina-1beta/metabolismo , Lipopolisacáridos/farmacología , Macrófagos/citología , Macrófagos/inmunología , Ratones , Proteína Quinasa 1 Activada por Mitógenos/genética , Proteína Quinasa 1 Activada por Mitógenos/inmunología , Proteína Quinasa 3 Activada por Mitógenos/genética , Proteína Quinasa 3 Activada por Mitógenos/inmunología , Inhibidor NF-kappaB alfa , FN-kappa B/genética , FN-kappa B/inmunología , Estrés Oxidativo , Transducción de Señal , Superóxido Dismutasa/genética , Superóxido Dismutasa/inmunología , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/metabolismoRESUMEN
Dehydrodieugenol, known as bis-eugenol, is a eugenol ortho dimer, and both compounds were able to exhibit anti-inflammatory and antioxidant activities in previous studies. Furthermore, eugenol showed antidepressant-like effect; however, the biological actions of bis-eugenol on experimental models for screening antidepressant activity are still unknown. The present study investigated a possible antidepressant-like activity of bis-eugenol in the forced swimming test (FST) and tail suspension test (TST) in mice and the involvement in the monoaminergic system in this effect. In addition, a neurochemical analysis on brain monoamines of mice acutely treated with bis-eugenol was also conducted. Bis-eugenol decreased the immobility time in the FST and TST without accompanying changes in ambulation in the open field test at 10 mg/kg, i.p.. Nevertheless, it induced ambulation at 25 and 50 mg/kg doses. The anti-immobility effect of bis-eugenol (10 and 50 mg/kg, i.p.) was prevented by pretreatment of mice with p-chlorophenylalanine (PCPA, 100 mg/kg, i.p., an inhibitor of serotonin synthesis, for four consecutive days), yohimbine (1 mg/kg, i.p., an α2-adrenoceptor antagonist), SCH23390 (15 µg/kg, s.c., a dopamine D1 receptor antagonist) and sulpiride (50 mg/kg, i.p., a dopamine D2 receptor antagonist). Monoamines analysis using high-performance liquid chromatograph revealed significant increase in the 5-HT, NE and DA levels in brain striatum. The present study indicates that bis-eugenol possesses antidepressant-like activity in FST and TST by altering dopaminergic, serotonergic and noradrenergic systems function.
Asunto(s)
Antidepresivos/uso terapéutico , Monoaminas Biogénicas/agonistas , Cuerpo Estriado/efectos de los fármacos , Depresión/tratamiento farmacológico , Modelos Animales de Enfermedad , Eugenol/análogos & derivados , Lignanos/uso terapéutico , Neuronas/efectos de los fármacos , Neuronas Adrenérgicas/efectos de los fármacos , Neuronas Adrenérgicas/metabolismo , Animales , Antidepresivos/administración & dosificación , Antidepresivos/efectos adversos , Antidepresivos/antagonistas & inhibidores , Conducta Animal/efectos de los fármacos , Monoaminas Biogénicas/metabolismo , Cuerpo Estriado/metabolismo , Depresión/metabolismo , Dopamina/química , Dopamina/metabolismo , Neuronas Dopaminérgicas/efectos de los fármacos , Neuronas Dopaminérgicas/metabolismo , Relación Dosis-Respuesta a Droga , Eugenol/administración & dosificación , Eugenol/efectos adversos , Eugenol/antagonistas & inhibidores , Eugenol/uso terapéutico , Conducta Exploratoria/efectos de los fármacos , Lignanos/administración & dosificación , Lignanos/efectos adversos , Lignanos/antagonistas & inhibidores , Masculino , Ratones , Neuronas/metabolismo , Norepinefrina/agonistas , Norepinefrina/metabolismo , Neuronas Serotoninérgicas/efectos de los fármacos , Neuronas Serotoninérgicas/metabolismo , Serotonina/química , Serotonina/metabolismo , Regulación hacia Arriba/efectos de los fármacosRESUMEN
Aniba riparia (Nees) Mez. (Lauraceae) is popularly known as "louro", and is found in Amazonia and in the Guianas, its distribution extends to the Andes. Alkamide alkaloids were isolated from its green fruit; they were denominated riparin I (methyl ether of N-benzoyl tyramine), riparin II (methyl ether of N-2-hydroxy-benzoyl tyramine) and riparin III (methyl ether of N-2,6-dihydroxy-benzoyl tyramine) in tribute to the plant. When administered orally and intraperitoneally to mice, riparin I and III are anxiolytic, yet without any sedative or muscle relaxing effects. The present study shows that variables such as extraction solvent, centrifugation force, and centrifugation time, are important in the simultaneous liquid-liquid extraction of riparin I and III from male and female Wistar rat blood in HPLC-UV studies. The study confirms matrix influence on simultaneous recovery and detection of riparin I and III. The effect of rat blood matrix for riparin I was -13.86%, while for riparin III it was -10.94%. The recovery for riparin I was 82.14%, while for riparin III it was 87.42%. The efficiency of the process was 73.25% for riparin I and 77.81% for riparin III, demonstrating an optimal method for simultaneous recovery of riparins I and III from the blood of rats. The matrix effect for rat blood showed values of 10.25% for riparin I and -83.01% for riparin III. Recovery for riparin I was 113.11%, whereas for riparin III it was 13.65%. The process efficiency of this method for female rat blood was 125.88% for riparin I and 2.58% for riparin III. Simultaneous recovery of riparin I and III from the blood of male and female rats using acetonitrile as the precipitating solvent, while centrifuged at 10,000 × g for 10 min demonstrated the importance of the parameters chosen for the extraction/recovery process of different analytes.
Asunto(s)
Benzamidas/sangre , Benzamidas/aislamiento & purificación , Lauraceae , Tiramina/análogos & derivados , Animales , Cromatografía Líquida de Alta Presión/métodos , Proteínas de la Matriz Extracelular/sangre , Femenino , Masculino , Unión Proteica/fisiología , Ratas , Ratas Wistar , Espectrofotometría Ultravioleta/métodos , Tiramina/sangre , Tiramina/aislamiento & purificaciónRESUMEN
In order to evaluate the effects produced by N-(2-hydroxybenzoyl) tyramine (riparin II) isolated from the unripe fruit of Aniba riparia (NEES) MEZ (Lauraceae) on the central nervous system, different behavioral tests were performed. Riparin II (rip II) was administered orally (p.o.) and intraperitoneally (i.p.) in male mice, at doses of 25, 50 and 75 mg/kg, and tested on elevated plus maze (EPM), open field, rota rod and hole board tests. The results revealed that rip II caused considered increase of the number of head dips in hole board test and increased the number of entries and the time of permanence in the open arms in plus maze test in both routes. No significant effect was evidenced on rota rod and open field test, except an increase observed in the number of rearing. These results showed that riparin II presents anxiolytic-like effects in the plus maze and hole board tests which are not influenced by the locomotor activity as detected in the open field test.
Asunto(s)
Ansiolíticos/farmacología , Benzamidas/farmacología , Lauraceae/química , Tiramina/análogos & derivados , Animales , Diazepam/farmacología , Relación Dosis-Respuesta a Droga , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Ratones , Tiramina/farmacologíaRESUMEN
This work presents the behavioral effects of riparin I (methyl ether of N-benzoyl tyramine) from unripe fruit of Aniba riparia (Lauraceae) on the elevated plus maze, open field, rota rod and hole board tests in mice. Riparin I was administered acutely by intraperitoneal (i.p.) and oral routes to male mice at doses of 25 and 50 mg/kg. The results showed that riparin I (25 and 50 mg/kg, i.p. and per os) increased the number of entries and the time of permanence in the open arms in the plus maze test. Similarly, in the hole board test, riparin I in both routes increased the number of head dips. Riparin I with both doses and routes had no effects on spontaneous motor activity in mice or in the rota rod test, but decreased the number of groomings. These results showed that riparin I by both administration routes has effects on the central nervous system with antianxiety effects on the plus maze and hole board tests. The substance is devoid of myorelaxant effects.
Asunto(s)
Ansiolíticos/farmacología , Benzamidas/farmacología , Lauraceae , Tiramina/análogos & derivados , Animales , Diazepam/farmacología , Frutas , Locomoción/efectos de los fármacos , Masculino , Ratones , Actividad Motora/efectos de los fármacos , Relajación Muscular/efectos de los fármacos , Extractos Vegetales/farmacología , Tiramina/farmacologíaRESUMEN
As alcamidas naturais constituem uma classe especial de alcalóide contendo uma função amida restrita a poucos constituintes na natureza. O objetivo deste estudo foi avaliar a ação da estrutura/atividade antimicrobiana de amidas isoladas de Aniba riparia (Nees) Mez. Lauraceae (riparinas I, III e XIII), sobre cepas multirresistentes de Staphylococcus aureus e Escherichia coli de origemhumana. Constatou-se neste estudo que as riparinas, apesar de suas diferenças estruturais, apresentaram atividades antimicrobianas semelhantes. No entanto, a riparina III (O-Metil-N-(2,6-dihidroxibenzoil)-Tiramina) foi a que apresentou maior potencial antimicrobiano.Todas as cepas de S. aureus, testadas, mostraram-se mais susceptíveis à ação das riparinas do que as cepas de E. coli.